Company intelligence / Profile preview

Biorez

New Haven, Connecticut, United States

Ownership: Private
Employees: ~4
Development stage: Other

Overview

The BioBrace implant, a bio-inductive scaffold, is FDA-cleared for various soft tissue reinforcement indications, with clinical data supporting improved tissue regeneration and joint stability. Acquisition by CONMED enables expanded commercial development

Therapeutic areas: Other
Modalities: DeviceBio-inductive scaffold
Industry: Implantable Medical Devices

Partnerships

Acquisition by CONMED; previously raised funds from various investors including venture firms (details undisclosed)

Beyond the preview

Go deeper on Biorez.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biorez.

Explore the full profile